首页> 美国卫生研究院文献>other >A Pilot Study to Assess the Feasibility of Transcutaneous Glomerular Filtration Rate Measurement Using Fluorescence-Labelled Sinistrin in Dogs and Cats
【2h】

A Pilot Study to Assess the Feasibility of Transcutaneous Glomerular Filtration Rate Measurement Using Fluorescence-Labelled Sinistrin in Dogs and Cats

机译:评价使用荧光标记的芥子油苷在狗和猫中进行经皮肾小球滤过率测量的可行性的初步研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In dogs and cats an assessment of renal function is often needed, however, existing methods including urine and plasma clearances are invasive, cumbersome and time consuming. This pilot study evaluated the feasibility of a transcutaneous glomerular filtration rate (GFR) measurement in dogs and cats. Additionally the optimal dose and location for the transcutaneous measurement device were investigated. Renal elimination of fluorescein-isothiocyanate-labelled sinistrin (FITC-S) was measured transcutaneously for 4 hours. The procedures were performed in awake, freely moving animals using escalating doses of FITC-S (10 mg/kg, 30 mg/kg, 50 mg/kg) with a wash-out period of at least 24 h in between. Multiple devices were placed on each animal. The resulting FITC-S disappearance curves were visually assessed to determine the most suitable location and the appropriate dose to reach an adequate transcutaneous peak signal for kinetic analysis. In both species 30 mg/kg were adequate for kinetic calculation. The most suitable place for the device was the lateral thoracic wall in dogs and the ventral abdominal wall in cats, respectively. Transcutaneous FITC-S clearance was then repeated using the optimal dose and location and in parallel with an additional plasma sinistrin clearance. Plasma elimination half-lives [min] were 26, 31 and 35, and corresponding transcutaneous elimination half-lives [min] were 26, 34 and 55, respectively in the dogs. Plasma elimination half-lives [min] were 51, 60 and 61, and corresponding transcutaneous elimination half-lives [min] were 75, 96 and 83, respectively in the cats. In conclusion, transcutaneous FITC-S clearance is a feasible method for the assessment of GFR in awake dogs and cats. It is noninvasive, well tolerated and easy to perform even in a clinical setting with results being readily available. A dose of 30 mg/kg of FITC-S seems adequate for kinetic assessment. Further studies are now needed to establish reference values and evaluate transcutaneous renal clearance in various conditions.
机译:在狗和猫中,经常需要评估肾功能,但是,包括尿液和血浆清除在内的现有方法是侵入性的,麻烦的且耗时的。这项初步研究评估了在猫和狗中进行经皮肾小球滤过率(GFR)测量的可行性。另外,研究了经皮测量设备的最佳剂量和位置。经皮测量4小时的肾脏荧光素异硫氰酸酯标记的芥子苷(FITC-S)的消除。该程序在清醒,自由活动的动物中使用递增剂量的FITC-S(10 mg / kg,30 mg / kg,50 mg / kg)进行,其间至少需要24小时的冲洗时间。在每只动物上放置多个装置。目视评估所得的FITC-S消失曲线,以确定最合适的位置和合适的剂量,以达到足够的经皮峰信号进行动力学分析。在两个物种中,30 mg / kg足以进行动力学计算。该设备最合适的地方分别是狗的胸外侧壁和猫的腹腹壁。然后使用最佳剂量和位置重复经皮FITC-S清除,并与另外的血浆芥子苷清除同时进行。犬的血浆消除半衰期[min]分别为26、31和35,相应的经皮消除半衰期[min]分别为26、34和55。在猫中,血浆消除半衰期[min]为51、60和61,相应的经皮消除半衰期[min]为75、96和83。总之,经皮FITC-S清除是评估清醒的猫和狗的GFR的可行方法。它具有无创性,良好的耐受性,即使在临床环境中也易于执行,其结果易于获得。 FITC-S的剂量为30 mg / kg似乎足以进行动力学评估。现在需要进一步的研究以建立参考值并评估各种情况下的经皮肾清除率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号